MedPageToday
MedPage Today) — The FDA declined to grant full approval to obeticholic acid (Ocaliva) for treating primary biliary cholangitis (PBC), Intercept Pharmaceuticals announced on Tuesday.
The decision follows a September meeting of the agency’s Gastrointestinal…
Read More
FDA Rejects Full Approval of Liver Disease Drug
Qiana Serna
12:20
MedPage Today) — The FDA declined to grant full approval to obeticholic acid (Ocaliva) for treating primary biliary cholangitis (PBC), Intercept Pharmaceuticals announced on Tuesday. The decision follows a September meeting of the agency’s Gastrointestinal…
